These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23738379)

  • 1. Training not required to prescribe sustained-release opioids.
    J Am Vet Med Assoc; 2013 May; 242(9):1191. PubMed ID: 23738379
    [No Abstract]   [Full Text] [Related]  

  • 2. Extended-release hydrocodone (Zohydro) for pain.
    Med Lett Drugs Ther; 2014 Jun; 56(1444):45-6. PubMed ID: 24933087
    [No Abstract]   [Full Text] [Related]  

  • 3. Blueprint for prescriber continuing education program.
    Center For Drug Evaluation And Research Food And Drug Administration
    J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):127-30. PubMed ID: 22764849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Professionalism and professional standards.
    Riley JH
    Vet Pathol; 2002 May; 39(3):413. PubMed ID: 12014511
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA acts to reduce harm from opioid drugs.
    J Pain Palliat Care Pharmacother; 2011; 25(3):296-7. PubMed ID: 21882983
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparing graduates for the future of veterinary medicine.
    Eyre P
    J Am Vet Med Assoc; 2011 May; 238(10):1241. PubMed ID: 21614805
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparing graduates for the future of veterinary medicine.
    Lewis H
    J Am Vet Med Assoc; 2011 May; 238(10):1241. PubMed ID: 21568764
    [No Abstract]   [Full Text] [Related]  

  • 8. Extended-release/long-acting opioid REMS may fill the need for prescribers' appropriate use education.
    Nicholson SC; Evanyo K; Salinas GD; Roepke N; Burton BS; Susalka D
    J Opioid Manag; 2012; 8(4):212-6. PubMed ID: 22941848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The licensure catch-22.
    Hardin L
    J Am Vet Med Assoc; 1999 Sep; 215(5):621-2. PubMed ID: 10476702
    [No Abstract]   [Full Text] [Related]  

  • 10. Opinions regarding the ECFVG program.
    Reynolds B
    J Am Vet Med Assoc; 2001 Jan; 218(2):191-2. PubMed ID: 11195815
    [No Abstract]   [Full Text] [Related]  

  • 11. Opinions regarding the ECFVG program.
    Burr Nyberg E
    J Am Vet Med Assoc; 2001 Jan; 218(2):192-3. PubMed ID: 11195816
    [No Abstract]   [Full Text] [Related]  

  • 12. Opinions regarding the ECFVG program.
    Gopal D
    J Am Vet Med Assoc; 2001 Jan; 218(2):191. PubMed ID: 11195814
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA to tighten labeling on long acting opioids.
    McCarthy M
    BMJ; 2013 Sep; 347():f5581. PubMed ID: 24030791
    [No Abstract]   [Full Text] [Related]  

  • 14. Manufacturers argue against mandatory training for opioid prescribers.
    Traynor K
    Am J Health Syst Pharm; 2010 Jan; 67(2):96. PubMed ID: 20065261
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequency of activities and procedures performed in private equine practice and proficiency expected of new veterinary school graduates.
    Hubbell JA; Saville WJ; Moore RM
    J Am Vet Med Assoc; 2008 Jan; 232(1):42-6. PubMed ID: 18167107
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids.
    Stanos S
    Phys Sportsmed; 2012 Nov; 40(4):12-20. PubMed ID: 23306411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Veterinary school accreditation: on a slippery slope?
    Marshak RR
    J Am Vet Med Assoc; 2011 Nov; 239(9):1183-7. PubMed ID: 21999788
    [No Abstract]   [Full Text] [Related]  

  • 18. A morphine/naltrexone combination (Embeda) for pain.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):22-3. PubMed ID: 20336033
    [No Abstract]   [Full Text] [Related]  

  • 19. PAVE program targeted in one of six resolutions.
    J Am Vet Med Assoc; 2001 Jun; 218(12):1871, 1877. PubMed ID: 11417725
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA chief defends Zohydro approval as US states rebel.
    McCarthy M
    BMJ; 2014 Apr; 348():g2939. PubMed ID: 24764572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.